No Data
No Data
Morgan Stanley Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $27
Ardent Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Ardent Health Partners, Inc. (ARDT)
Seven Ardent Health Facilities Earn 2024 Leapfrog Top Hospital Award for Outstanding Quality and Safety
J.P. Morgan Maintains Ardent Health Partners(ARDT.US) With Hold Rating, Raises Target Price to $20
Beyond The Numbers: 6 Analysts Discuss Ardent Health Partners Stock
No Data
nolan ratchford : agreed, its a great stock, extremely undervalued currently and the business is solid and relatively new. people are overlooking this right now. as we see the bulls retreat, this is the stock that will rise! at this price, its a great pick up. too 35$ in 2025
MrSuperStonk OP nolan ratchford : it dosent have alot of exposition so it will rise very slowly and only based on revenue. 35 is a stretch but 25 ish is possible by summer
nolan ratchford MrSuperStonk OP : yes, thats what most would think. but revenue is high for a 2.4 billion market cap, yet 6 billion in revenue a year and profitable, aswell as the market being overextended which means money should soon flow into value stocks and this will be targeted by a few bigger funds soon forsure, they can compare to older companies in the same sector that have less health or growth possibilities and much more market capital . believe me, i know this is a estimate of 25 probably this year but the estimates dont factor in these things. so remember it by year end that i believe it will hit 35 sometime this year. i understand where your coming from. this ones different
nolan ratchford nolan ratchford : also i meant 2025 , not this year lol